Holen Sie sich die Stockscreener-App
288.45
2.01%
-5.93
Handel nachbörslich:
291.50
3.05
+1.06%
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) - Yahoo Finance Singapore
20 Best Performing Stocks in 2025 - Insider Monkey
Will Praxis Precision Medicines Inc. stock see PE expansionPerformance Line Overview & quick comparison of popular models - ulpravda.ru
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Praxis Precision (PRAX) Announces Key Leadership Changes - GuruFocus
Praxis Precision Medicines appoints new board members, promotes executives By Investing.com - Investing.com India
Praxis Precision Medicines appoints new board members, promotes executives - Investing.com
Praxis Precision Medicines Announces Key Management Appointments - TradingView — Track All Markets
Praxis Precision Medicines Announces New Board Appointments and Executive Promotions to Drive Growth and Commercial Readiness - Quiver Quantitative
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments - Chartmill
Will Praxis Precision Medicines Inc. stock reach all time highs in 2025 - ulpravda.ru
How strong is Praxis Precision Medicines Inc. stock balance sheet2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru
Will Praxis Precision Medicines Inc. stock benefit from commodity pricesJuly 2025 Volume & Real-Time Market Sentiment Alerts - ulpravda.ru
S P Trends: Is Praxis Precision Medicines Inc. stock a smart buy before Fed meeting2025 Technical Patterns & Expert Approved Trade Ideas - ulpravda.ru
Is Praxis Precision Medicines Inc. stock a smart buy before Fed meetingJuly 2025 Selloffs & Real-Time Stock Movement Alerts - ulpravda.ru
Is Praxis Precision Medicines Inc. stock a buy in volatile marketsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - ulpravda.ru
Praxis rises on ulixacaltamide gaining Breakthrough Therapy status - MSN
PRAX Stock Surge: Time to Buy? - StocksToTrade
Praxis Precision Medicines Inc. (PRAX) secures analyst confidence after key FDA and trial wins - MSN
Praxis Precision Medicines Announces Major Underwritten Equity Offering - TipRanks
Praxis Precision Medicines Announces Underwritten Offering - TradingView — Track All Markets
Praxis Precision Medicines (PRAX) Valuation Check After A Strong 90 Day Share Price Run - Yahoo Finance
Praxis Precision stock rises as $575 million share sale clears at $260 - TechStock²
Praxis Precision Medicines edges down after $575 mln stock sale - TradingView — Track All Markets
Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Praxis Precision Medicines, Inc. Announces Proposed Public Offering - Sahm
Praxis Precision Prices $575 Mln Public Offering At $260/shr - Nasdaq
Praxis Precision (PRAX) Announces Public Offering of Stock and W - GuruFocus
Praxis Precision Medicines (PRAX) Announces $575M Public Offerin - GuruFocus
Praxis Precision prices $575M stock offering at $260 - MSN
Praxis Precision Medicines prices public offering at $260 per share By Investing.com - Investing.com Australia
Praxis Precision Medicines prices public offering at $260 per share - Investing.com
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering - Yahoo Finance
Praxis Precision Medicines Announces Pricing of Public Offering of Common Stock at $260 Per Share - Quiver Quantitative
Biotech targeting CNS disorders lines up $575M stock sale - Stock Titan
Praxis Precision Medicines reports preliminary $925 million in cash and securities - Investing.com Australia
Praxis Precision Medicines announces proposed public offering By Investing.com - Investing.com Nigeria
Praxis Precision Medicines reports preliminary $925 million in cash and securities By Investing.com - Investing.com South Africa
After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis - Investing.com
Praxis Precision Medicines slips after announcing equity offering plans - TradingView — Track All Markets
Praxis Precision Medicines announces proposed public offering - Investing.com India
Praxis Precision Medicines stock falls on proposed public offering By Investing.com - Investing.com South Africa
TD Cowen lifts Praxis Precision Medicines Inc. (PRAX) price target amid NDA for essential tremor treatment - MSN
Praxis Precision Medicines, Inc. Announces Proposed Public Offering - Benzinga
Praxis Precision Medicines (PRAX) Valuation Check After Big Three Year Return And Price To Book Premium - Sahm
Needham maintains Praxis Precision Medicines (PRAX) buy recommendation - MSN
Deutsche Bank sets $111 target for Praxis Precision shares - MSN
Praxis Precision Medicines Earnings Notes - Trefis
Praxis Precision Medicines stock rises as FDA grants breakthrough designation By Investing.com - Investing.com South Africa
Praxis Precision Medicines stock rises as FDA grants breakthrough designation - Investing.com Australia
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):